Prestige Consumer Healthcare Inc.
Close on Oct 19, 2026
- Market cap
- $2.37B
- P/E (TTM)
- 13.9
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q1 FY2027 Ended Jun 30, 2026 | Aug 6, 2026 | Before market open | $265.70M | $0.61 | $0.98 |
| Q4 FY2026 Ended Mar 31, 2026 | May 13, 2026 | During market hours | $281.60M | $1.13 | $1.23 |
| Q3 FY2026 Ended Dec 31, 2025 | Feb 5, 2026 | Before market open | $283.40M | $0.97 | $1.14 |
| Q2 FY2026 Ended Sep 30, 2025 | Nov 6, 2025 | Before market open | $274.10M | $0.86 | $1.07 |
| Q1 FY2026 Ended Jun 30, 2025 | Aug 7, 2025 | Before market open | $249.50M | $0.95 | – |
| Q4 FY2025 Ended Mar 31, 2025 | May 8, 2025 | Before market open | $296.50M | $1.00 | $1.32 |
| Q3 FY2025 Ended Dec 31, 2024 | Feb 6, 2025 | Before market open | $290.30M | $1.22 | $1.22 |
| Q2 FY2025 Ended Sep 30, 2024 | Nov 7, 2024 | Before market open | $283.80M | $1.09 | $1.09 |
| Q1 FY2025 Ended Jun 30, 2024 | Aug 8, 2024 | Before market open | $267.10M | $0.98 | $0.90 |
| Q4 FY2024 Ended Mar 31, 2024 | May 14, 2024 | During market hours | $277.00M | $0.98 | $1.02 |
| Q3 FY2024 Ended Dec 31, 2023 | Feb 8, 2024 | Before market open | $282.70M | $1.06 | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Projected FY'27 GAAP Diluted EPSGAAP | Projected FY'27 | $4.18 to $4.28 | Lowered |
| Projected FY'27 Non-GAAP Free Cash Flownon-GAAP | Projected FY'27 | $251.00M | Raised |
| Projected FY'27 GAAP Net cash provided by operating activitiesGAAP | Projected FY'27 | $277.00M | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Prestige Consumer Healthcare filed with the SEC
Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter FY 2027 Results August 6th, 2026 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Prestige Consumer Healthcare Inc Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc Completes Acquisition of Breathe
Material agreement · Acquisition or disposition completed · New financial obligation · Other events · EX-99.1 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health
Material agreement · Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Full-Year Fiscal 2026 Results May 14th, 2026 Exhibit 99.2
Material agreement · Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Announcement of Agreement to Acquire Breathe Right
Material agreement · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Prestige Consumer Healthcare Announces Agreement
Material agreement · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Third Quarter FY 26 Results February 5, 2026 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Second Quarter FY 26 Results November 6, 2025 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results
Material agreement · Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter FY 2026 Results August 7th, 2025 Exhibit 99.2
Material agreement · Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Full-Year Fiscal 2025 Results May 8th, 2025 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Third Quarter FY 2025 Results February 6th, 2025 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Second Quarter FY 2025 Results November 7th, 2024 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter FY 2025 Results August 8th, 2024 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
M a y 1 5 t h , 2 0 2 4 Full-Year FY 24 Results Exhibit 99.2
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Third Quarter FY 2024 Results February 8th, 2024 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Second Quarter FY 2024 Results November 2nd, 2023 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter FY 2024 Results August 3rd, 2023 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
M a y 4 t h , 2 0 2 3 Full-Year FY 23 Results Exhibit 99.2
Results of operations · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Third Quarter Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
F e b r u a r y 2 n d , 2 0 2 3 Third Quarter FY 2023 Results 1 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Second Quarter FY 2023 Results November 3rd, 2022 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
First Quarter FY 2023 Results August 4th, 2022 Exhibit 99.2
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022
Results of operations · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K